|
25I-NBOH (NBOH-2CI, Cimbi-27) is a derivative of the phenethylamine derived hallucinogen 2C-I. It acts as a potent agonist for the 5HT2A receptor, with a Ki of 0.061nM at the human 5HT2A receptor, similar to the better-known compound 25I-NBOMe, making it some twelve times the potency of 2C-I itself. ''In vitro'' tests showed this compound acted as an agonist but animal studies have not been reported. While the ''N''-benzyl derivatives of 2C-I were significantly increased in binding activity to 5HT2A receptor fragments, compared to 2C-I, the ''N''-benzyl derivatives of DOI were less active, compared to DOI. It was discovered in 2006 by a team at Purdue University. ==See also== * 2CBCB-NBOMe (NBOMe-TCB-2) * 2CBFly-NBOMe (NBOMe-2C-B-Fly) * 25B-NBOMe (NBOMe-2C-B) * 25C-NBOMe (NBOMe-2C-C) * 25I-NBMD (NBMD-2C-I) * 25I-NBOMe (NBOMe-2C-I) * 25TFM-NBOMe (NBOMe-2C-TFM) * 25I-NBF (NBF-2C-I) * 25B-NBOH * 25C-NBOH (NBOH-2C-C) 抄文引用元・出典: フリー百科事典『 ウィキペディア（Wikipedia）』 ■ウィキペディアで「25I-NBOH」の詳細全文を読む スポンサード リンク
|